Literature DB >> 19202101

Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.

Narveen Jandu1, Zoë Jingjing Zeng1, Kathene C Johnson-Henry1, Philip M Sherman1.   

Abstract

Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 inhibits interferon (IFN)-gamma-stimulated tyrosine phosphorylation of signal transducer and activator of transcription (STAT)-1 in epithelial cells. We determined the effects of probiotics on EHEC-mediated disruption of IFN-gamma-stimulated STAT-1 activation in epithelial cell lines. Confluent Intestine 407, HEp-2 and Caco-2 epithelial cells were pre-treated (3 h) with either probiotics or surface-layer proteins derived from Lactobacillus helveticus R0052 prior to infection with EHEC O157:H7 strain CL56 (m.o.i. 100:1, 6 h, 37 degrees C in 5% CO2). Subsequently, cells were washed and stimulated with human recombinant IFN-gamma (50 ng ml(-1), 0.5 h, 37 degrees C) followed by whole-cell protein extraction and immunoblotting for tyrosine-phosphorylated STAT-1. Relative to uninfected cells, STAT-1-activation was reduced after EHEC O157:H7 infection. Pre-incubation with the probiotic L. helveticus R0052 followed by EHEC infection abrogated pathogen-mediated disruption of IFN-gamma-STAT-1 signalling. As determined using Transwell inserts, probiotic-mediated protection was independent of epithelial cell contact. In contrast, pre-incubation with boiled L. helveticus R0052, an equal concentration of viable Lactobacillus rhamnosus R0011, or surface-layer proteins (0.14 mg ml(-1)) did not restore STAT-1 signalling in EHEC-infected cells. The viable probiotic agent L. helveticus R0052 prevented EHEC O157:H7-mediated subversion of epithelial cell signal transduction responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19202101     DOI: 10.1099/mic.0.021931-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties.

Authors:  Abofu Alemka; Marguerite Clyne; Fergus Shanahan; Thomas Tompkins; Nicolae Corcionivoschi; Billy Bourke
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 2.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

3.  Multistrain probiotic modulation of intestinal epithelial cells' immune response to a double-stranded RNA ligand, poly(i·c).

Authors:  Chad Macpherson; Julie Audy; Olivier Mathieu; Thomas A Tompkins
Journal:  Appl Environ Microbiol       Date:  2013-12-27       Impact factor: 4.792

4.  Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.

Authors:  Sonia S Yoon; Jun Sun
Journal:  Gastroenterol Res Pract       Date:  2011-07-26       Impact factor: 2.260

5.  Health-Promoting Properties of Lactobacillus helveticus.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Front Microbiol       Date:  2012-11-19       Impact factor: 5.640

6.  Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile.

Authors:  Michelle M Merrigan; Anilrudh Venugopal; Jennifer L Roxas; Farhan Anwar; Michael J Mallozzi; Bryan A P Roxas; Dale N Gerding; V K Viswanathan; Gayatri Vedantam
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.